Showing results (1831-1840 of 1,899) with videos related to

Sort By:
Pageof 190
Immunotherapy|December 21, 2023
A trispecific antibody induces potent tumor-directed T-cell activation and antitumor activity by CD3/CD28 co-engagementLi Chen, Wenjing Qian, Fangfang Pan, et al.
Immunotherapy|December 19, 2023
Oncolytic viruses in lung cancer treatment: a review articleHanie Sakhi, Mohadeseh Arabi, Amir Ghaemi, et al.
Immunotherapy|December 19, 2023
Imaging findings can't mean everything in the era of immunotherapy: a case report and literature reviewXiangye Zhao, Kewei Ma, Xiaobo Ma, et al.
Immunotherapy|December 6, 2023
Molecular interactions of antibodies with PD-1/PD-L1 proteinsSofia Vasilakaki, Ioannis Vathiotis, Emmanouil Panagiotou, et al.
Immunotherapy|March 15, 2024
Outcomes for pembrolizumab stratified by pemetrexed maintenance post pembrolizumab-platinum-pemetrexed induction in metastatic non-small-cell lung cancerJerome H Goldschmidt, Srinivas Annavarapu, Divea Venkatasetty, et al.
Immunotherapy|February 29, 2024
Association between sex and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysisJianxiong Lai, Xiaohong Kuang, Yi Fu, et al.
Immunotherapy|April 5, 2024
Prognostic value of peripheral blood neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, pan-immune-inflammation value and systemic immune-inflammation index for the efficacy of immunotherapy in patients with advanced gastric cancerMaodong Fu, Xiuping Zhang, Feng Shen, et al.
Immunotherapy|June 18, 2024
Pembrolizumab in an HIV-infected patient with glioblastomaCarlen A Yuen, Silin Bao, Melike Pekmezci, et al.
Immunotherapy|November 7, 2023
Immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemiaSyed B Ali, Bryone Kuss, Chris Karapetis, et al.
Immunotherapy|October 12, 2023
Integrase inhibitors: current protagonists in antiretroviral therapyJohn D Loaiza, Mateo Chvatal-Medina, Juan C Hernandez, et al.
Pageof 190